Comparing DyLight800-7 and DyLight800-9 with DyLight800-8 and DyLight800-10, it was demonstrated that the N-bromobenzyl substituent significantly increased the PSMA+ PIP tumor uptake. This evidence concerns the gene FOLH1 and neoplasm.